发明名称 |
NOVEL RETIGABINE COMPOSITION |
摘要 |
<p>The present invention relates to an oral dosage form comprising N-(2-amino-4-(fluorobenzylamino)-phenyl)carbamic acid ethyl ester (retigabine) or a pharmaceutically acceptable salt or solvate thereof, to a process for preparing such a dosage form and to the use of such a dosage form in medicine.</p> |
申请公布号 |
SG181827(A1) |
申请公布日期 |
2012.07.30 |
申请号 |
SG20120045449 |
申请日期 |
2011.01.18 |
申请人 |
GLAXO GROUP LIMITED |
发明人 |
BURKE, MATTHEW;RHODES, CHARLES, HARDING |
分类号 |
|
主分类号 |
|
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|